11. Financial analysis :
comparing 1H 2011- 2H 2012
Net financial debt
Net financial
debt is
increasing!
2011 2012 11
12. Forecast
Last trading update (12-10-2012)
Organic growth : + 5,4%
MANAGEMENT CONFIRMS :
Profitability is
expected to grow
faster than turnover
growth.
12
13. Forecast
ANALYSTS CONSENSUS OF PROFITABILITY :
Share price : € 14,3 = 1,23 * 11,62
12-2011 12-2012 12-2013 12-2014
act est est est
EPS 1,08 1,23 1,32 1,54
P/E 13,24 11,62 10,83 9,29
PERSONAL OPINION :
Share price today (10nov) €14,01
Price target end 2014 : 1,54 * 11,62 = €17,9
Return 27,76% on 2 years annual + 13%
10 times return of a saving
account!
13
14. Forecast
PERSONAL OPINION :
A possible extra trigger :
Arseus can be a target for a great pharma-player
CAN DRIVE THE SHARE
PRICE EVEN HIGHER!
14
15. Conclusion
Non—cyclical industry
High growth potential for long term
LOW RISK INVESTMENT with a change of a GOOD RETURN
6/2/2013 next annual results
15